CI vs CNC
Cigna and Centene Corporation, both Healthcare
Cigna is the larger company at $74B against $30B. Over the past year CNC returned +160% against +6.3% for CI. Ryufin's sector-relative Smart Score puts CNC ahead, 8/10 against 6/10.
| Figure | CI | CNC |
|---|---|---|
| Last close | $281 | $65.47 |
| Market cap | $74B | $30B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 11.6 | n/a |
| Dividend yield | 2.2% | n/a |
| 1-year return | +6.3% | +160% |
| 5-year return | +34% | -4.6% |
| Ryufin Smart Scoresector-relative, 1–10 | 6/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Cigna
Revenue of $72B in Q2 2026, net income $1.9B. Its largest reported line is Network Pharmacy, 49% of the disclosed total.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 54% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.